Satouchi K et al. |
Application of selected ion monitoring to determination of platelet-activating factor. |
1983 |
J. Biochem. |
pmid:6423622
|
McManus LM et al. |
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. |
1983 |
Immunopharmacology |
pmid:6832960
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Ninio E et al. |
Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187. |
1983 |
Biochim. Biophys. Acta |
pmid:6405792
|
Alam I et al. |
Human and rabbit platelets form platelet-activating factor in response to calcium ionophore. |
1983 |
Thromb. Res. |
pmid:6407140
|
Ostermann G et al. |
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor. |
1983 |
Thromb. Res. |
pmid:6408754
|
Jouvin-Marche E et al. |
Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils. |
1983 |
Eur. J. Pharmacol. |
pmid:6134631
|
Sano K et al. |
A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. |
1983 |
J. Biol. Chem. |
pmid:6218169
|
Vargaftig BB et al. |
Synergized activation of human platelets by epinephrine and platelet-activating factor-acether is adenosine diphosphate and thromboxane A2-independent. |
1983 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:6221558
|
Mueller HW et al. |
1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1983 |
Lipids |
pmid:6419001
|
Holt PG et al. |
Platelet serotonin release by human polymorphonuclear leucocytes stimulated by cotton dust bacteria. |
1983 |
Clin. Exp. Immunol. |
pmid:6831770
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Page CP et al. |
PAF-acether: a putative mediator of asthma and inflammation. |
1983 |
Agents Actions Suppl. |
pmid:6575595
|
O'Flaherty JT and Wykle RL |
Biology and biochemistry of platelet-activating factor. |
1983 |
Clin Rev Allergy |
pmid:6370406
|
Tiffany ML |
Technical considerations for platelet aggregation and related problems. |
1983 |
Crit Rev Clin Lab Sci |
pmid:6370596
|
Pieroni G and Hanahan DJ |
Metabolic behavior of acetyl glyceryl ether phosphorylcholine on interaction with rabbit platelets. |
1983 |
Arch. Biochem. Biophys. |
pmid:6870274
|
Camussi G et al. |
The release of platelet-activating factor from human endothelial cells in culture. |
1983 |
J. Immunol. |
pmid:6415166
|
Bonnet J et al. |
Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. |
1983 |
Prostaglandins |
pmid:6419289
|
Morgat JL et al. |
Radio-labelling of 1-O-alkyl, 2-O-acetyl, sn-glycero-3-phosphorylcholine, 1-O-(9,10-di3H)-octadecyl PAF-acether. |
1982 |
Agents Actions |
pmid:7164942
|
Convert O et al. |
1H NMR of PAF-acether: influence of solvent on its structure. |
1982 |
Agents Actions |
pmid:7164943
|